PHILADELPHIA--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, announced today that it will be presenting pre-clinical data on its antibiotic compounds in a poster presentation at the 46th annual meeting of the American Society for Microbiology's (ASM's) Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. More than 12,000 physicians, researchers and other healthcare professionals from around the globe gather each year at ICAAC to foster worldwide solutions to the problem of infectious diseases.
